Evidence map›Paper›PMID 30518749›Full record

ArticleCell death & disease2018

Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome.

Elisabetta Caprini, Antonella Bresin, Cristina Cristofoletti, Mauro Helmer Citterich, Valeria Tocco, Enrico Scala, Alessandro Monopoli, Roberto Benucci, Maria Grazia Narducci, Giandomenico Russo

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. TCR Pathway Mutations in Mature T Cell Lymphomas.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Elisabetta CapriniIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Antonella BresinIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Cristina CristofolettiIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Mauro Helmer CitterichIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Valeria ToccoDepartment of Paediatric Haematology and Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Bambino Gesù" Children's Hospital, Rome, Italy.
Enrico ScalaIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.ORCID http://orcid.org/0000-0002-9391-9168
Alessandro MonopoliIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Roberto BenucciIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy.
Maria Grazia NarducciIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy. m.narducci@idi.it.
Giandomenico RussoIstituto Dermopatico dell'Immacolata, IDI-IRCCS, Rome, Italy. g.russo@idi.it.
Istituto Dermopatico dell'Immacolata · ITBambino Gesù Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous T-cell lymphoma is a group of incurable extranodal non-Hodgkin lymphomas that develop from the skin-homing CD4

Indexed as

Gene Expression Regulation, NeoplasticGenetic Predisposition to DiseaseGerm-Line MutationApoptosisCell Line, TumorCell SurvivalDNA Copy Number VariationsHumansOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotidePTEN PhosphohydrolaseReactive Oxygen SpeciesRetinoblastoma Binding ProteinsSezary SyndromeSkinSkin NeoplasmsPTEN PhosphohydrolasePTEN protein, humanRB1 protein, humanReactive Oxygen SpeciesRetinoblastoma Binding ProteinsTP53 protein, humanTumor Suppressor Protein p53Ubiquitin-Protein LigasesZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1

Identifiers

PMID30518749
PMCPMC6281581
OpenAlexW2902468125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.